Research ArticleOriginal Article
Open Access

Gender differences in risk profile and outcome of Middle Eastern patients undergoing percutaneous coronary intervention

Mohamad I. Jarrah, Ayman J. Hammoudeh, Dalal B. Al-Natour, Yousef S. Khader, Ramzi A. Tabbalat, Imad A. Alhaddad and Susan M. Kullab
Saudi Medical Journal February 2017, 38 (2) 149-155; DOI: https://doi.org/10.15537/smj.2017.2.16301

References

  1. ↵
    1. Gehani AA,
    2. Al-Hinai AT,
    3. Zubaid M,
    4. Almahmeed W,
    5. Hasani MR,
    6. Yusufali AH,
    7. et al.
    (2014) Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. Eur J Prev Cardiol 21:400–410.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Regitz-Zagrosek V,
    2. Oertelt-Prigione S,
    3. Prescott E,
    4. Franconi F,
    5. Gerdts E,
    6. Foryst-Ludwig A,
    7. et al.
    (2016) Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J 37:24–34.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Mehta LS,
    2. Beckie TM,
    3. DeVon HA,
    4. Grines CL,
    5. Krumholz HM,
    6. Johnson MN,
    7. et al.
    (2016) Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation 133:916–947.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Sjauw KD,
    2. Stegenga NK,
    3. Engstrom AE,
    4. van der Schaaf RJ,
    5. Vis MM,
    6. Macleod M,
    7. et al.
    (2010) The influence of gender on short- and long-term outcome after primary PCI and delivered medical care for ST-segment elevation myocardial infarction. EuroIntervention 5:780–787.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Johnston N,
    2. Schenck-Gustafsson K,
    3. Lagerqvist B
    (2011) Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J 32:1331–1336.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Chieffo A,
    2. Hoye A,
    3. Mauri F,
    4. Mikhail GW,
    5. Ammerer M,
    6. Grines C,
    7. et al.
    (2010) Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. EuroIntervention 5:773–779.
    OpenUrlPubMed
  7. ↵
    1. De Carlo M,
    2. Morici N,
    3. Savonitto S,
    4. Grassia V,
    5. Sbarzaglia P,
    6. Tamburrini P,
    7. et al.
    (2015) Sex-related outcomes in elderly patients presenting with non-ST-segment elevation acute coronary syndrome. Insights from the Italian Elderly ACS Study. JACC Cardiovasc Interv 8:791–796.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Cutlip DE,
    2. Windecker S,
    3. Mehran R,
    4. Boam A,
    5. Cohen DJ,
    6. van Es GE,
    7. et al.
    (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Subherwal S,
    2. Bach RG,
    3. Chen AY,
    4. Gage BF,
    5. Rao SV,
    6. Newby LK,
    7. et al.
    (2009) Baseline risk of major bleeding in non-ST-segment elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation 119:1873–1882.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Vaccarino V,
    2. Badimon L,
    3. Corti R,
    4. de Wit C,
    5. Dorobantu M,
    6. Hall A,
    7. et al.
    (2011) Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 90:9–17.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Ghali WA,
    2. Faris PD,
    3. Gallbraith PD,
    4. Norris CM,
    5. Curtis MJ,
    6. Suanders LD,
    7. et al.
    (2002) Sex differences in access to coronary revascularization after cardiac catheterization: importance of detailed clinical data. Ann Intern Med 136:723–732.
    OpenUrlPubMedWeb of Science
  12. ↵
    1. Reynolds HR,
    2. Farkouh ME,
    3. Lincoff AM,
    4. Hsu A,
    5. Swahn E,
    6. Sadowski ZP,
    7. et al.
    (2007) Impact of female sex on death and bleeding after fibrinolytic treatment of MI in GUSTO V. Arch Intern Med 167:2054–2060.
    OpenUrlCrossRefPubMedWeb of Science
    1. Pancholy SB,
    2. Shantha GP,
    3. Patel T,
    4. Cheskin LJ
    (2014) Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med 174:1822–1830.
    OpenUrl
  14. ↵
    1. Hvelplund A,
    2. Galatius S,
    3. Madsen M,
    4. Rasmussen JN,
    5. Rasmussen S,
    6. Madsen JK,
    7. et al.
    (2010) Women with acute coronary syndrome are less invasively examined and subsequently less treated than men. Eur Heart J 31:684–690.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Mikhail GW,
    2. Gerber RT,
    3. Cox DA,
    4. Ellis SG,
    5. Lasala JM,
    6. Orminston JA,
    7. et al.
    (2010) Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent. Results of the “TAXUS Woman” analysis. JACC Cardiovasc Interv 3:1250–1259.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Seth A,
    2. Serruys PW,
    3. Lansky A,
    4. Hermiller J,
    5. Onuma Y,
    6. Miquel-Herbert K,
    7. et al.
    (2010) A pooled gender based analysis comparing the Xience V everolimus-eluting stent and the Taxus paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis. EuroIntervention 5:788–794.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Onuma Y,
    2. Kukreja N,
    3. Daemen J,
    4. Garcia-Garcia HM,
    5. Gonzalo N,
    6. Cheng JM,
    7. et al.
    (2009) Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv 2:603–610.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Hamm CW,
    2. Bassand JP,
    3. Agewall S,
    4. Bax J,
    5. Boersma E,
    6. Bueno H,
    7. et al.
    (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999–3054.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Gabizon I,
    2. Lonn E
    (2015) Young women with acute myocardial infarction and the post-hospital syndrome. Circulation 132:149–151.
    OpenUrlFREE Full Text
  20. ↵
    1. Kalyani RR,
    2. Lazo M,
    3. Ouyang P,
    4. Turkbey E,
    5. Chevalier K,
    6. Brancati F,
    7. et al.
    (2014) Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care 37:830–838.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Shaw LJ,
    2. Bugiardini R,
    3. Merz CN
    (2009) Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 54:1561–1575.
    OpenUrlFREE Full Text
  22. ↵
    1. Vaccarino V,
    2. Parsons L,
    3. Every NR,
    4. Barron HV,
    5. Krumholz HM
    (1999) Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 341:217–225.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Wenger NK,
    2. Brindis RG,
    3. Casey DE Jr.,
    4. Ganiats TG,
    5. Holmes DR Jr.,
    6. Jaffe AS,
    7. et al.
    (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130:e344–e426.
    OpenUrlFREE Full Text
    1. Mehran R,
    2. Kini AS
    (2010) Sex-related outcomes after drug-eluting stent. Should we “never mind” or “mind” the gap? JACC Cardiovasc Interv 3:1260–1261.
    OpenUrlFREE Full Text
  25. ↵
    1. Krumholz HM,
    2. Douglas PS,
    3. Lauer MS,
    4. Pasternak RC
    (1992) Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med 116:785–790.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Ahmed B,
    2. Dauerman HL
    (2013) Women, bleeding, and coronary intervention. Circulation 127:641–649.
    OpenUrlFREE Full Text
    1. Alexander KP,
    2. Chen AY,
    3. Newby LK,
    4. Schwartz JB,
    5. Redberg RF,
    6. Hochman JS,
    7. et al.
    (2006) CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHA guidelines) Investigators. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 114:1380–1387.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Ndrepepa G,
    2. Berger PB,
    3. Mehilli J,
    4. Seyfarth M,
    5. Neumann FJ,
    6. Schömig A,
    7. et al.
    (2008) Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 51:690–697.
    OpenUrlFREE Full Text
  29. ↵
    1. Lindsey JB,
    2. Marso SP,
    3. Pencina M,
    4. Stolker JM,
    5. Kennedy KF,
    6. Rihal C,
    7. et al.
    (2009) Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv 2:1074–1082.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Eikelboom JW,
    2. Mehta SR,
    3. Anand SS,
    4. Xie C,
    5. Fox KA,
    6. Yusuf S
    (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114:774–782.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Nikolsky E,
    2. Mehran R,
    3. Dangas G,
    4. Fahy M,
    5. Na Y,
    6. Pocock SJ,
    7. et al.
    (2007) Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 28:1936–1945.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Lenzen MJ,
    2. Boersma E,
    3. Bertrand ME,
    4. Maier W,
    5. Moris C,
    6. Piscione F,
    7. et al.
    (2005) Management and outcome of patients with established coronary artery disease: Euro Heart Survey on coronary revascularization. Eur Heart J 26:1169–1179.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    1. Wijns W,
    2. Kolh PH
    (2010) Experience with revascularization procedures does matter: low volume means worse outcome. Eur Heart J 31:1954–1957.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section